glp-1 trial results today New clinical data validates Truveta real-world data study GLP1 agonists: current and future

People on Medicare can get GLP-1s covered by Part D plans only if they are used for a medically accepted FDA-approved indication other than obesity, like type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea

In addition, their improved blood pressure, cholesterol, blood sugar levels reverted back to their pre-trial levels, highlighting the potential drawbacks associated with GLP-1 agonists in the long-run

Negative evidence: A study in Indonesian individuals showed that supplementation with glutathione combined with vitamin C, alpha-lipoic acid, and zinc did not significantly lighten skin compared to placebo (Sitohang et al., J Clin Aesthet Dermatol, 2021) [63]

I mean, like, everyone has, like, some hormonal acne

Best when taken as directed by a qualified healthcare professional